PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Nonsteroidal anti-inflammatory agent slows rate of progression of neurodegenerative disease

2013-12-27
(Press-News.org) Contact information: Jenny Eriksen Leary
jenny.eriksen@bmc.org
617-638-6841
The JAMA Network Journals
Nonsteroidal anti-inflammatory agent slows rate of progression of neurodegenerative disease Among patients with familial amyloid polyneuropathy, a lethal, genetic neurodegenerative disease, use of the nonsteroidal anti-inflammatory agent diflunisal compared with placebo for 2 years reduced the rate of progression in neurological impairment and preserved quality of life, according to a study appearing in the December 25 issue of JAMA.

Familial amyloid polyneuropathy is characterized by progressive neurologic deficits and disability which prove fatal if left untreated. Fewer than 10,000 people are estimated to be clinically affected worldwide, according to background information in the article. Diflunisal showed potential benefit in a phase 1 study.

John L. Berk, M.D., of the Boston University School of Medicine, and colleagues, pursuing the NIH mission to repurpose old drugs, randomized 130 patients from Sweden, Italy, Japan, England, and the United States to receive diflunisal (n=64) or placebo (n=66) twice daily for 2 years to determine the effect of diflunisal on polyneuropathy progression in patients with familial amyloid polyneuropathy.

Patients randomized to diflunisal exhibited less progression of polyneuropathy than those assigned to placebo. The inhibitory effect of diflunisal on neuropathy progression was detectable at 1 and 2 years, and at 2 years, 29.7 percent of the diflunisal group compared to 9.4 percent of the placebo group exhibited neurological stability. Physical quality of life stabilized from the beginning of the study to 2 years in those assigned to diflunisal treatment while decreasing in the placebo group.

The authors write that their trial is pivotal for several reasons: it is the first randomized trial involving a broad cross-section of the spectrum of disease; it provides invaluable natural history data on the rate of neurological disease progression; and it establishes that diflunisal, a low-cost treatment, is well tolerated by familial amyloid polyneuropathy patients with a spectrum of neuropathy.

"Although longer-term follow-up studies are needed, these findings suggest benefit of this treatment for familial amyloid polyneuropathy."

###

(doi:10.l001/jama.2013.283815; Available pre-embargo to the media at http://media.jamanetwork.com)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

END



ELSE PRESS RELEASES FROM THIS DATE:

Prolonged exposure therapy found beneficial in treating adolescent girls with PTSD

2013-12-27
Prolonged exposure therapy found beneficial in treating adolescent girls with PTSD (PHILADELPHIA) – Researchers at Penn Medicine report in the December 25 issue of JAMA that a modified form of prolonged exposure therapy ...

Antidepressants for bipolar disorder

2013-12-27
Antidepressants for bipolar disorder The use of antidepressants in the treatment of bipolar disorder remains controversial. Some studies and treatment guidelines suggest that antidepressant treatment for bipolar disorder may have the potential to increase the manic ...

NASA sees the last of Cyclone Bruce in Southern Indian Ocean

2013-12-27
NASA sees the last of Cyclone Bruce in Southern Indian Ocean Tropical Cyclone Bruce is winding down in the Southern Indian Ocean as wind shear and cooler waters affect the storm. NASA's Aqua satellite flew over Bruce on December 24 and showed that wind shear is having ...

Kinect-based virtual reality training promotes brain reorganization after stroke

2013-12-27
Kinect-based virtual reality training promotes brain reorganization after stroke The Kinect-based virtual reality system for the Xbox 360 enables users to control and interact with the game console without the need to touch a game controller, and provides rehabilitation ...

Activating P300 protein contributes to repair of hippocampal neuronal DNA injuries

2013-12-27
Activating P300 protein contributes to repair of hippocampal neuronal DNA injuries Various medications have been developed to treat neurodegenerative disorders, and drugs without significant side effects are gaining widespread interest such disorders. Brain Research ...

Epigenetics enigma resolved

2013-12-27
Epigenetics enigma resolved First structure of enzyme that removes methylation Scientists have obtained the first detailed molecular structure of a member of the Tet family of enzymes. The finding is important for the field of epigenetics because Tet enzymes chemically ...

Researchers complete a milestone in defining the genetic basis of rheumatoid arthritis

2013-12-27
Researchers complete a milestone in defining the genetic basis of rheumatoid arthritis MANHASSET, NY – An international group of investigators has discovered new genes, pathways and cell types that are involved in inherited susceptibility to rheumatoid ...

International team completes systematic, genomic study of cervical cancer

2013-12-27
International team completes systematic, genomic study of cervical cancer Findings point to potential therapeutics, shed light on HPV role Researchers from the Boston area, Mexico, and Norway have completed a comprehensive genomic analysis of cervical ...

New genetic risk factor for type 2 diabetes revealed

2013-12-27
New genetic risk factor for type 2 diabetes revealed Samples from Mexican, Latin American populations shed light on disease Cambridge and Boston, MA; Los Angeles, CA; Mexico City, Mexico. Wed. December 25, 2013 – An international team of researchers ...

Researcher says extensive use of antibiotics in agriculture creating public health crisis

2013-12-27
Researcher says extensive use of antibiotics in agriculture creating public health crisis University of Calgary's Aidan Hollis advocates user fees on non-human antibiotics use Citing an overabundance in the use of antibiotics by the agriculture and aquaculture industries ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Nonsteroidal anti-inflammatory agent slows rate of progression of neurodegenerative disease